In This Section

Pancreatic Cancer

September 29 – October 2, 2020
AACR Virtual Special Conference

Abstract Submission DeadlineTuesday, August 4, 2020, 12 p.m. ET
Sign Up for Additional Information About the Virtual Conference

AACR Special Conference on Pancreatic Cancer: Notice of Termination and Rescheduling

The American Association for Cancer Research (AACR) has made the difficult decision, after careful consideration and a comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak, to terminate the AACR Special Conference on Pancreatic Cancer originally scheduled for September 29–October 2, 2020, in Philadelphia, PA. A rescheduled virtual meeting is being planned.

We recognize that the new data, exchange of information, and opportunities for collaboration offered by this meeting are highly valued by the pancreatic cancer research community; therefore, we are working to reschedule the meeting as a virtual event close to or during the originally scheduled dates. 

Information on the rescheduled meeting will be sent by email once it becomes available. All meeting registrations will be refunded by June 30, 2020. If you have a room reservation at the Loews Philadelphia Hotel, your cancellation will be accepted at no charge up to 48 hours in advance of your scheduled check-in date; please contact the hotel at (215) 627-1200 to cancel your reservation as soon as possible. Many airlines have adjusted their rebooking and cancellation policies in response to the COVID-19 crisis.  Please contact your airline or booking agent directly to cancel your travel arrangements to Philadelphia. 

Abstracts that were submitted for the meeting will be carried over to the virtual event and, if accepted, will be included for presentation in the rescheduled virtual meeting. If you wish to withdraw an abstract, please email your request to [email protected].

There will also be an opportunity for colleagues to submit abstracts for presentation at the virtual meeting.  Please watch for an announcement pertaining to the deadline for abstract submission.

The AACR deeply appreciates your patience and understanding during this unfortunate situation.  Please look for emails in the coming months as we work to reschedule this program as soon as possible. If you have any questions, please email [email protected].

Our heartfelt sympathies go out to everyone who has been impacted by this global health crisis.  Thank you for your dedication to the AACR and to its mission.

Conference Cochairs

Dafna Bar-Sagi, New York University Langone Medical Center, New York, New York
Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Ben Z. Stanger, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
Brian M. Wolpin, Dana-Farber Cancer Institute, Boston, Massachusetts

Pancreatic cancer will account for approximately 45,750 deaths in the United States this year alone and is poised to become the third leading cause of cancer-deaths by 2030. The seventh AACR Special Conference on pancreatic cancer will showcase many of the cutting-edge discoveries and promising advances in the understanding and treatment of pancreatic cancer. Plenary Session topics will cover all aspects of pancreatic cancer research, from basic research discoveries to evidence-based clinical trials, convening world-renown experts to discuss the latest advances.

Lead Supporters

Professional Educational Grants

AstraZeneca
Bristol-Myers Squibb
Ipsen


Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available

#AACRPAN20